Crossmark

Moderate-Intensity Atorvastatin and Ezetimibe Combination Therapy Versus High-Intensity Atorvastatin in Patients with Angina Pectoris who Underwent Percutaneous Coronary Intervention

Crossref DOI link: https://doi.org/10.1007/s10557-025-07729-7

Published Online: 2025-08-01

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sohn, Seo Young

Kim, Yun Jin

Doh, Joon-Hyung

Cho, Sung Woo https://orcid.org/0000-0003-3983-817X
Funding

Funding for this research was provided by:

Korean Society of Interventional Cardiology (2021-04)
License Information

Text and Data Mining valid from 2025-08-01

Version of Record valid from 2025-08-01
More Information

Article History

Accepted: 27 May 2025

First Online: 1 August 2025

Declarations

:

: This study was performed in accordance with the Helsinki Declaration and was approved by the institutional review board of Inje University Ilsan Paik Hospital (IRB no. 2021–12-006).

: The institutional review board of Inje University Ilsan Paik Hospital confirmed that the requirement for obtaining informed consent was not applicable because this study used anonymous administrative claim data.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below